Regulus Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CAPR | D | Capricor Therapeutics, Inc. | 1.47 | |
RGLS | D | Regulus Therapeutics Inc. | 6.44 | |
SPRO | F | Spero Therapeutics, Inc. | -1.54 | |
ABOS | F | Acumen Pharmaceuticals, Inc. | -1.45 | |
PRQR | F | ProQR Therapeutics B.V. | -0.60 | |
LPTX | F | LEAP THERAPEUTICS, INC. | -4.59 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Alnylam Pharmaceuticals
Biotechnology
Oligonucleotide
Alzheimer's Disease
Amyloid
Amyloid Beta
Amyloidosis
Antimicrobial Resistance
Atherosclerosis
Bacterial Infections
Biology
Blastoma
Cancer
Carcinoma
Cardiovascular Disease
Cystic Fibrosis
Disease
Drug Resistant Bacterial Infections
Evolutionary Biology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | C | iShares Neuroscience and Healthcare ETF | 0.49 | |
CSML | C | IQ Chaikin U.S. Small Cap ETF | 0.17 | |
IWC | C | iShares Microcap ETF | 0.06 | |
AVSC | C | Avantis U.S. Small Cap Equity ETF | 0.01 | |
DFAS | D | Dimensional U.S. Small Cap ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Alnylam Pharmaceuticals
Biotechnology
Oligonucleotide
Alzheimer's Disease
Amyloid
Amyloid Beta
Amyloidosis
Antimicrobial Resistance
Atherosclerosis
Bacterial Infections
Biology
Blastoma
Cancer
Carcinoma
Cardiovascular Disease
Cystic Fibrosis
Disease
Drug Resistant Bacterial Infections
Evolutionary Biology
- Regulus Therapeutics
Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles